https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Implications of a needs assessment intervention for people with progressive cancer: impact on clinical assessment, response and service utilisation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28169 Palliative Care Needs Assessment Guidelines and Needs Assessment Tool: Progressive Disease-Cancer (NAT: PD-C) on clinical assessment, response and service utilisation. Study setting: Three major oncology treatment centres in NSW, Australia. Study design: Between March 2007 and December 2009, 219 people with advanced cancer were recruited to complete bi-monthly telephone interviews. The intervention, introduced after at least two baseline interviews, involved training health professionals to complete the NAT: PD-C with patients approximately monthly. Data collection: Rates of service use and referrals were compared pre- and post-introduction of the NAT: PD-C. Rates of completion of the tool; its impact on consultation length; and the types of needs and follow-up care to address these were also assessed. Principal findings: The NAT: PD-C had a high rate of completion; identified needs consistent with those self-reported by patients in interviews; and did not alter consultation length. No changes in the number of health professionals seen by patients were found pre- and post-intervention. Conclusion: The NAT: PD-C is an efficient and acceptable strategy for supporting needs-based cancer care that can potentially be incorporated into standard routine care without increasing the burden on care providers.]]> Sat 24 Mar 2018 07:36:35 AEDT ]]> Improving outcomes for people with progressive cancer: interrupted time series trial of a needs assessment intervention https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28170 health system and information and patient care and support needs. Conclusion: These resources have the potential as an efficient and acceptable strategy for supporting needs-based cancer care. Further work is required to determine their unique contribution to improvements in patient outcomes.]]> Fri 10 Mar 2023 18:17:43 AEDT ]]>